Scinovex
article Open AccessTop 1% cited

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

New England Journal of Medicine · 2000 · Vol. 342(3) · pp. 145–153
Salim Yusuf

Abstract

Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or heart failure.

Blood Pressure and Hypertension StudiesRenin-Angiotensin System StudiesHeart Failure Treatment and ManagementRamiprilMedicineInternal medicinePlaceboMyocardial infarctionHeart failureEjection fractionACE inhibitorRelative riskStroke (engine)

MeSH terms

AgedAngiotensin-Converting Enzyme InhibitorsCardiovascular DiseasesDiabetes MellitusDouble-Blind MethodFemaleHumansMaleMiddle AgedMyocardial InfarctionRisk FactorsTreatment OutcomeRamiprilStrokeDiabetes Complications
Citations
8,641
FWCI
434.53
field-weighted impact
References
18
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.